Drug Kinetics – News and Features

A drug candidate has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.

A technique developed by researchers to deliver medication through the blood-brain barrier has shown promise in a preclinical study for treating glioblastoma, the most common human brain cancer.

A new method for selecting aptamers, or "chemical antibodies," created by Penn State engineers takes only days to complete, instead of the months typically needed for traditional methods.

UCLA researchers have developed a new treatment method using a tiny nanocapsule to help boost the immune response, making it easier for the immune system to fight and kill solid tumors.

Because metal-organic frameworks (MOFs) are so structurally and chemically diverse, they could be used for many applications, such as drug delivery and environmental clean-up. Researchers still need to get a better understanding of how they function.

The FDA has approved the use of soundwaves to break down tumors for liver cancer treatment, providing a promising alternative to surgery, radiotherapy and chemotherapy.

This article explores the current state of drug monitoring and highlights the important role precision dosing can play in optimizing patient care.

A new study has detailed the potential of a new drug to mimic the beneficial effects of exercise in mouse models. The drug induced weight loss and improved endurance in obese mice, enabling them to run 50% further and lose 12% of their body weight.

Coating DNA with a pure form of glass has resulted in a new material that is four times stronger than steel but incredibly lightweight. Further research could lead to new engineering or defense applications.

A new drug delivery system based on the suckers lining octopuses’ tentacles has been shown off in a new study.